A Study of Mosliciguat in PH-ILD

Clinical trial NCT06635850 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06635850
Sponsor: Pulmovant, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension Interstitial Lung Disease Lung Diseases Vascular Diseases Cardiovascular Diseases Fibrosis

Start date: 2024-10-29
Primary completion: 2026-12-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.